By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PAREXEL International 

Corporate Headquarters
195 West Street
Waltham  Massachusetts  02451  U.S.A.
Phone: 781-487-9900 Fax: 781-487-0525



At PAREXEL, the best minds in the industry are simplifying the journey from science to new treatments—and getting them into the hands of those who need them most. If you join us, you can be a part of that. Through innovative processes and technology, your journey with us will not only be challenging but truly rewarding. PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries.

Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement.

PAREXEL Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates approximately 75 locations in over 50 countries around the world, and has more than 15,000 employees. For more information about PAREXEL International, visit

Key Statistics

Ownership: Public

Web Site: PAREXEL International
Employees: 15,000 worldwide
Symbol: PRXL

Company News
PAREXEL International (PRXL) Announces Date Of First Quarter Fiscal Year 2016 Earnings Release And Conference Call 10/1/2015 9:54:30 AM
Society For Clinical Research Sites Welcomes PAREXEL International (PRXL) As New Global Impact Partner 10/1/2015 8:38:24 AM
PAREXEL International (PRXL)’s Head Of Learning And Development Named To 2015 PharmaVOICE 100 Most Inspiring People In The Life Sciences List 9/23/2015 11:14:21 AM
PAREXEL International (PRXL) Announces $200 Million Accelerated Share Repurchase Program 9/17/2015 8:56:20 AM
PAREXEL International (PRXL) Announces Stock Repurchase Program 9/15/2015 6:11:13 AM
PAREXEL International (PRXL) To Present At Wells Fargo Healthcare Conference And UBS Healthcare Supply Channel 1x1 Conference 9/2/2015 9:57:25 AM
PAREXEL International (PRXL) Names Maykin Ho To Board Of Directors 8/26/2015 7:29:23 AM
PAREXEL International (PRXL) Receives CEO Cancer Gold Standard Accreditation 8/13/2015 10:23:16 AM
PAREXEL International (PRXL) Reports Fourth Quarter And Fiscal Year 2015 Results; Confirms Previous Revenue And Adjusted EPS Guidance For Fiscal Year 2016 8/6/2015 9:41:25 AM
PAREXEL International (PRXL) Stays Mum as 200 Ex-GlaxoSmithKline (GSK) Workers are Reportedly Being Laid Off Today 7/30/2015 6:23:31 AM